These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 1693445)
41. [Tumor markers in hepatoma, gallbladder-biliary tract and pancreas cancer]. Nakahara M; Fujisawa K Gan To Kagaku Ryoho; 1987 Nov; 14(11):3010-9. PubMed ID: 2445292 [TBL] [Abstract][Full Text] [Related]
43. [Critical study of current tumoral markers]. Touitou Y; Bogdan A Bull Cancer; 1988; 75(3):247-62. PubMed ID: 2453233 [TBL] [Abstract][Full Text] [Related]
44. [Course studies by means of tumor markers]. Quentmeier A Aktuelle Probl Chir Orthop; 1980; 74():43-6. PubMed ID: 6156606 [No Abstract] [Full Text] [Related]
45. Tumor markers for the diagnosis, prognosis, treatment and follow-up of gynaecological tumors. Ulsperger E; Karrer K Bull Soc Sci Med Grand Duche Luxemb; 1989; 126(1):33-43. PubMed ID: 2545372 [TBL] [Abstract][Full Text] [Related]
46. Establishment and characterization of a seminoma cell-line (S2). von Keitz AT; Riedmiller H; Neumann K; Gutschank W; Fonatsch C Investig Urol (Berl); 1994; 5():28-31. PubMed ID: 7536523 [No Abstract] [Full Text] [Related]
47. Advances in the use of tumor markers. Schwartz MK Compr Ther; 1990 Nov; 16(11):51-7. PubMed ID: 1702695 [No Abstract] [Full Text] [Related]
48. Value of human chorionic gonadotropin compared to CEA in discriminating benign from malignant effusions. Lamerz R; Stoetzer OJ; Mezger J; Brandt A; Darsow M; Wilmanns W Anticancer Res; 1999; 19(4A):2421-5. PubMed ID: 10470169 [TBL] [Abstract][Full Text] [Related]
49. Biological markers of human tumors and monitoring of cancer treatment. Tanneberger S; Nissen E; Ziegenbein R Arch Geschwulstforsch; 1979; 49(6):528-34. PubMed ID: 94534 [TBL] [Abstract][Full Text] [Related]
50. Cancer markers of the 1990s. Comparison of the new generation of markers defined by monoclonal antibodies and oncogene probes to prototypic markers. Sell S Clin Lab Med; 1990 Mar; 10(1):1-37. PubMed ID: 1691962 [TBL] [Abstract][Full Text] [Related]
51. Tumor markers: value and limitations in the management of cancer patients. Bates SE; Longo DL Cancer Treat Rev; 1985 Sep; 12(3):163-207. PubMed ID: 2416441 [TBL] [Abstract][Full Text] [Related]
52. [Significance of tumor markers in clinical oncology]. Gericke D; Drahovsky D Med Klin; 1979 May; 74(19):701-9. PubMed ID: 88005 [No Abstract] [Full Text] [Related]
53. [Diagnosis and management of cancer using tumor markers]. Torigoe T; Kato H Nihon Sanka Fujinka Gakkai Zasshi; 1983 Sep; 35(9):1672-6. PubMed ID: 6194233 [No Abstract] [Full Text] [Related]
55. Best practice in primary care pathology: review 14. Cabrera-Abreu JC; Smellie WS; Bowley R; Shaw N J Clin Pathol; 2012 Feb; 65(2):101-5. PubMed ID: 21896580 [TBL] [Abstract][Full Text] [Related]
56. [Tumor markers--possibilities and limitations]. Rose H; Saul G; Wolf G; Moldenhauer H; Kehrberg G Radiobiol Radiother (Berl); 1984; 25(1):7-19. PubMed ID: 6203136 [No Abstract] [Full Text] [Related]
57. Diagnostic significance and clinical application of tumour-associated antigens in man with special reference to the carcinoembryonic antigen. Wagener C; Breuer H J Clin Chem Clin Biochem; 1977 Oct; 15(10):529-43. PubMed ID: 72783 [No Abstract] [Full Text] [Related]
58. [Present status of tumor markers]. Hirai H Hum Cell; 1988 Mar; 1(1):1-9. PubMed ID: 2484806 [TBL] [Abstract][Full Text] [Related]
59. Immunologic tests in diagnosis of cancer. Herberman RB Am J Clin Pathol; 1977 Nov; 68(5 Suppl):688-98. PubMed ID: 72502 [TBL] [Abstract][Full Text] [Related]
60. [Gastric cancer with bone metastasis from the viewpoint on oncodevelopmental gene products]. Ohyama S; Yonemura Y; Hashimoto T; Sawa T; Miwa K; Miyazaki I Nihon Gan Chiryo Gakkai Shi; 1987 Jun; 22(5):1013-9. PubMed ID: 2447212 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]